The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #25614 · Form 4 · 0001301120-25-000039

Serina Therapeutics, Inc. · Exercise / conversion · Common Stock

Serina Therapeutics, Inc. · Transacted December 23, 2025 · Filed December 29, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Serina Therapeutics, Inc. records an exercise / conversion involving Common Stock on December 23, 2025. The reported quantity was 4,100. The filing date is December 29, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001708599
Security type
Non-derivative
Acquisition type
Exercise / conversion · Code M
Quantity acquired
4,100
Reported price
0.06
Reference value
246
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
4,100
Ownership description
Not reported
SEC acceptance time
Dec 29, 2025, 11:40 AM EST
10b5-1 indication
Indicated in filing

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

SER · NYSE · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
The stock options are fully vested.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.